+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Innovations and Growth Opportunities in AI-Based Diagnostics, Point-of-Care and Chronic Disease Management Solutions

  • PDF Icon

    Report

  • 34 Pages
  • May 2021
  • Region: Global
  • Frost & Sullivan
  • ID: 5398205

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The innovations in this issue cover various AI-enabled diagnostic and screening solutions. The issue also profiles various advanced point-of-care diagnostics and emerging chronic disease management solutions such as insulin patches and artificial pancreas. These innovations portray the diversity in their technology readiness levels, indicating an immediate or potential market impact. The growth opportunities for all these advanced medical device technologies are also covered in this issue.


The Advanced MedTech TOE analyzes and reports new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of CT, MRI, NM, PET, ultrasound, X-ray, neurology, ophthalmology, respiratory/anesthesia, wound care and management, surgical tools and instrumentation, drug delivery, orthopedics, endoscopy, cardiology, and monitoring. In addition, relevant developments in fusion technologies, functional imaging technology, interventional cardiology and image-guided surgery and healthcare IT-related areas such as PACS, medical information storage, and disaster recovery/business continuance will also be covered.


Medical devices and imaging technology and innovation research cover cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms.


Table of Contents

1. Innovations in Medical Devices and Imaging


  • Imedis Medical, Hamerkaz, Israel
  • Lung Passport, Minsk, Belarus
  • Glycardial Diagnostics S.L., Barcelona, Spain
  • Usmima, Barcelona, Spain
  • Iatros, Bayern, Germany
  • Vara, Berlin, Germany
  • Aignostics, Berlin, Germany
  • Aevice Health Pte. Ltd., Singapore
  • Medo, Canada
  • Parasym, UK
  • Humanoptics, Germany
  • Edwards Lifesciences, CA, US
  • Sonendo, CA, US
  • Defymed, France
  • Brain Navi Biotechnology, Taiwan
  • Next Science Limited, Australia
  • Tilak Healthcare S.A.S, France
  • Feeltect, Ireland
  • Theator Inc., Israel
  • Alveo Technologies Inc., CA, US
  • Cequr SA, Switzerland

2. Key Contacts


Companies Mentioned

A selection of companies mentioned in this report includes:

  • Aevice Health Pte. Ltd.
  • Aignostics
  • Alveo Technologies Inc.
  • Brain Navi Biotechnology
  • Cequr SA
  • Defymed
  • Edwards Lifesciences
  • Feeltect
  • Glycardial Diagnostics S.L.
  • Humanoptics
  • Iatros
  • Imedis Medical
  • Lung Passport
  • Medo
  • Next Science Limited
  • Parasym
  • Sonendo
  • Theator Inc.
  • Tilak Healthcare S.A.S
  • Usmima
  • Vara